
Mesaflux 1.2 CR Tablet
Marketer
H & Care Incorp
Salt Composition
Mesalazine (1200mg)
Overview Mesaflux 1.2 CR Tablet
Colitrol 1.2 CR tablets are an anti-inflammatory medication indicated for managing ulcerative colitis, a type of inflammatory bowel disease. This medication alleviates symptoms like abdominal pain, rectal bleeding, and diarrhea by targeting bowel inflammation. Colitrol 1.2 CR tablets may also be prescribed for Crohn's ileocolitis. Always take this medication with food, adhering strictly to your physician's prescribed dosage and regimen. Continuing treatment as directed is crucial; premature discontinuation can lead to symptom recurrence and disease exacerbation. Common side effects include nausea, vomiting, abdominal discomfort, headache, pruritus, flatulence, and diarrhea. Report any persistent, worsening, or bothersome side effects to your doctor; management strategies may be available. Seek immediate medical assistance if you experience a severe allergic reaction, indicated by facial, lip, tongue, or throat swelling; unusual bleeding or bruising; skin rash; fever; sore throat; or extreme fatigue. Prior to commencing treatment, inform your doctor of any liver or kidney impairments, gastric obstructions, or other relevant medical conditions, including pregnancy or breastfeeding. Your age may influence treatment suitability. Always disclose all other medications you are currently using, as interactions are possible.
Uses of Mesaflux 1.2 CR Tablet
Inflammatory bowel diseases, encompassing ulcerative colitis and Crohn's disease.
Major Benefits of Mesaflux 1.2 CR Tablet:
Follow your doctor's instructions or consult the product label for dosage guidelines. Mesaflux 1.2 CR Tablet can be administered with or without food, however, consistent daily timing is recommended.
Common Side effects of Mesaflux 1.2 CR Tablet:
- Stomach pain/epigastric pain
- Flatulence
- Headache
- Vomiting
- Diarrhea
- Nausea
- Abdominal pain
- Rash
How to use Mesaflux 1.2 CR Tablet:
Follow your physician's instructions or consult the product information leaflet for usage guidance. Mesaflux 1.2 CR Tablets can be administered with or without food; however, consistent daily timing is recommended.
How Mesaflux 1.2 CR Tablet works:
Aminosalicylate drug Mesaflux 1.2 CR Tablet acts by inhibiting the synthesis of prostaglandins, inflammatory mediators in the gut. This action diminishes intestinal ulceration, bleeding, and pain, while also mitigating future disease exacerbations.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Mesaflux 1.2 CR Tablet requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Mesaflux 1.2 CR Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Mesaflux 1.2 CR Tablet while breastfeeding is likely inadvisable. Studies in humans indicate potential transfer to breast milk, posing a risk to the infant. If you're using Mesaflux 1.2 CR Tablet, carefully observe your baby for diarrhea.
DrivingSAFE
Driving ability is typically unaffected by Mesaflux 1.2 CR Tablet.
KidneyCAUTION
Patients with kidney impairment should use Mesaflux 1.2 CR Tablet cautiously, potentially requiring dosage modification under medical supervision. Mesaflux 1.2 CR Tablet is contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Mesaflux 1.2 CR Tablets. Dosage modification may be necessary. A physician's advice is recommended.
What if you forget to take Mesaflux 1.2 CR Tablet :
Should you forget a Mesaflux 1.2 CR Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Mesaflux 1.2 CR Tablet
| Label | Value |
|---|---|
| Chemical Category | Salicylic Acid Derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Mesalamine (5-ASA) |
